Anthropic acquires Mithril Medicine to run drug programs with Claude
Founder Cody Tranbarger will continue Mithril's muscular-dystrophy research and start additional programs; the current evidence is preclinical.
By Ryan Merket · Published
Primary source: x.com
Why it matters
Anthropic is bringing an AI-coordinated biotech program in-house, putting its claim that one operator can run drug development to an early preclinical test.
Anthropic said on October 27th that it acquired Mithril Medicine, a small biotech founded by Cody Tranbarger (@Prof_Oak_), and will use the company as part of its own drug-discovery work with Claude. Tranbarger is joining Anthropic to continue Mithril's muscular-dystrophy research and start additional programs, extending the AI lab's work from software partnerships into drug development it operates directly.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.